Current state of Alzheimer’s fluid biomarkers-Reference-Cited by-同舟云学术

Current state of Alzheimer’s fluid biomarkers

Published:2018-11-28 Issue:6 Volume:136 Page:821-853
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Molinuevo José Luis,Ayton Scott,Batrla Richard,Bednar Martin M.,Bittner Tobias,Cummings Jeffrey,Fagan Anne M.,Hampel Harald,Mielke Michelle M.,Mikulskis Alvydas,O’Bryant Sid,Scheltens Philip,Sevigny Jeffrey,Shaw Leslie M.,Soares Holly D.,Tong Gary,Trojanowski John Q.,Zetterberg Henrik,Blennow Kaj

Funder

Roche Diagnostics International

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s00401-018-1932-x/fulltext.html

Reference408 articles.

1. Agnello L, Bivona G, Novo G, Scazzone C, Muratore R, Levantino P et al (2017) Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study. Scand J Clin Lab Invest 77:428–432. https://doi.org/10.1080/00365513.2017.1335880

2. Alcolea D, Martínez-Lage P, Sánchez-Juan P, Olazáran J, Antúnez C, Izagirre A et al (2015) Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology 85:626–633. https://doi.org/10.1212/wnl.0000000000001859

3. Alcolea D, Vilaplana E, Pegueroles J, Montal V, Sánchez-Juan P, González-Suárez A et al (2015) Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer’s disease. Neurobiol Aging 36:2018–2023. https://doi.org/10.1016/j.neurobiolaging.2015.03.001